ArticleOncotarget2022

HOXB9 mediates resistance to chemotherapy and patient outcomes through the TGFβ pathway in pancreatic cancer.

Naokazu Chiba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.